Literature DB >> 6441722

Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases.

A F Leger, J P Massin, M F Laurent, M Vincens, M Auriol, O B Helal, G Chomette, J C Savoie.   

Abstract

Iodine-induced thyrotoxicosis was documented in eighty-five cases. Eighty per cent occur in apparently normal thyroid glands; 60% among them occur in males. Amiodarone accounted for 50% of iodine-induced thyrotoxicosis. Mean thyroid hormone levels at diagnosis were: FT1: 21.7 (normal mean: 7.5, arbitrary units); T3: 4.53 nmol 1(-1) (normal: 2.30 nmol 1(-1). Mean 131I- 24-h uptake was 3.5% (normal range in France 25-45%) and was activated by exogenous TSH (mean 27%). The spontaneous cure in nontreated cases was observed within an average 6 months. A phase of biological hypothyroidism (mean FT1: 3.7, T3: 1.23 nmol 1(-1), TSH: 9.6 microU ml-1 (normal TSH range: 1-7 microU ml-1] preceded the return to euthyroidism. Intrathyroid iodine content measured by X-ray fluorescence was high, then fell gradually. Thyroid tissue study showed a large quantity of intrathyroid iodine and the overiodination of thyroglobulin. Histological and electron microscopic studies are reported. Prednisone and in some cases propylthiouracile were found to be effective.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441722     DOI: 10.1111/j.1365-2362.1984.tb01212.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  23 in total

1.  The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.

Authors:  B Uzzan; E Pussard; A Leon; D Bekhechi; A Krivitzky; E Modigliani; G Perret; R Vassy; A Berdeaux; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Amiodarone-induced thyrotoxicosis responding to oral steroid therapy.

Authors:  M Mercer
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

3.  Atrial fibrillation due to late amiodarone-induced thyrotoxicosis.

Authors:  Ibrahim Halil Kurt; Talat Yigit; Bulent Mustafa Karademir
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 4.  Thyroid consequences of Chernobyl accident in the countries of the European Community.

Authors:  J Malone; J Unger; F Delange; R Lagasse; J E Dumont
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

5.  Carbimazole--resistant thyrotoxicosis.

Authors:  B Corvilain; P Schinohoritis
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

6.  Amiodarone and thyroid hormone metabolism.

Authors:  W M Wiersinga; M D Trip
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

7.  Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.

Authors:  M Stäubli; A Troendle; B Schmid; P Balmer; B Kohler; H Studer; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.

Authors:  F Bogazzi; E Martino; E Dell'Unto; S Brogioni; C Cosci; F Aghini-Lombardi; C Ceccarelli; A Pinchera; L Bartalena; L E Braverman
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

9.  Amiodarone-induced thyrotoxicosis: is there a place for surgery?

Authors:  M Meurisse; E Hamoir; M D'Silva; J Joris; G Hennen
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

10.  Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.

Authors:  F Aghini-Lombardi; S Mariotti; P V Fosella; L Grasso; A Pinchera; L E Braverman; E Martino
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.